ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,101 | 83.64398 | 0 | male | 0 | 12 | 819 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 14,988 | 10,007.9531 | 10,994.6094 | 18 | white | 25.5 | 31 | 0.570923 | 0.459961 | 1 | 0 | 0 | metastatic | 0.7 | 0.6 | no dnr | 12 | 116 | 9.798828 | 66 | 32 | 36 | 242.5 | 1.399902 | 0.699951 | 2.099609 | 139 | 7.349609 | 170 | 18 | 1,795 | 0 | 3 | no(M2 and SIP pres) | 3 |
7,102 | 76.56396 | 1 | male | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 6 | 20 | $11-$25k | 41 | 3,525 | 2,471.7988 | 3,008.38867 | 30 | white | 31.097656 | 76 | 0.181976 | 0.050995 | 1 | 0 | 0 | no | null | null | dnr before sadm | 0 | 107 | 20.699219 | 103 | 34 | 35.59375 | 167.5 | 2.199707 | 0.399963 | 1.299805 | 142 | 7.359375 | 157 | 12 | 5,360 | null | 2 | <2 mo. follow-up | 2 |
7,103 | 70.94897 | 0 | female | 0 | 18 | 820 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 53,884 | 34,887.6562 | 41,764.2812 | 42.333313 | white | 27.5 | 31 | 0.670898 | 0.574951 | 6 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 18 | 58 | 22.097656 | 122 | 38 | 38.29688 | 176.65625 | 2.099609 | 0.699951 | 5.299805 | 145 | 7.439453 | 138 | 68 | 617 | null | 0 | no(M2 and SIP pres) | 0 |
7,104 | 44.112 | 1 | male | 0 | 6 | 369 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 5,430 | 3,820.9727 | 4,681.81641 | 3 | white | 29.398438 | 26 | 0.730957 | 0.578979 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 63 | 6.5 | 61 | 24 | 36.19531 | 309.5 | 1.899902 | 0.699951 | 1.199951 | 142 | 7.539062 | 113 | 39 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,105 | 28.523 | 1 | female | 0 | 4 | 708 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 5,666 | 3,811.1543 | 4,416.05859 | 15 | white | 16.296875 | 12 | 0.794922 | 0.565918 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 4 | 95 | 9.699219 | 69 | 20 | 36.29688 | 442.8125 | 4.099609 | 1 | 1.099854 | 136 | 7.449219 | 123 | 10 | 2,900 | null | 0 | null | 0 |
7,106 | 43.603 | 0 | female | 0 | 3 | 817 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 5,065 | 2,676.707 | 3,611.36914 | null | white | 13.599609 | 14 | 0.945923 | 0.908936 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 70 | 8.298828 | 176 | 20 | 37.89844 | null | 4 | 1 | 0.799927 | 134 | null | 94 | 14 | 1,500 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,107 | 79.55597 | 1 | male | 0 | 35 | 98 | Coma | Coma | 0 | 16 | $11-$25k | 9 | 68,866 | 45,992.9688 | 49,307.1562 | 21 | hispanic | 16.597656 | 43 | 0.641968 | 0.580933 | 6 | 0 | 0 | no | 0.67 | 0.7 | no dnr | 35 | 85 | null | 114 | 24 | 36.09375 | 136 | null | null | 0.899902 | 136 | 7.299805 | 129 | 9 | 2,175 | null | 1 | adl>=4 (>=5 if sur) | 1 |
7,108 | 62.29199 | 0 | male | 0 | 3 | 817 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 2,223 | 1,608.5732 | 1,986.05957 | null | white | 16.097656 | 18 | 0.791992 | 0.665894 | 1 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 3 | 122 | 10.199219 | 109 | 24 | 35.69531 | 229.625 | 3.799805 | 0.799927 | 0.799927 | 136 | 7.30957 | 120 | 14 | 1,900 | null | null | no(M2 and SIP pres) | 2.431152 |
7,109 | 90.52399 | 1 | female | 1 | 7 | 7 | CHF | COPD/CHF/Cirrhosis | 2 | 5 | under $11k | 0 | 6,025 | 4,134.9375 | 4,368.52734 | 6 | white | 16.296875 | 34 | 0.822998 | 0.712891 | 1 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 6 | 144 | 14.298828 | 138 | 13 | 36.69531 | 134.65625 | 2.099609 | 1.699951 | 5.199219 | 134 | 7.269531 | 178 | 63 | 1,126 | 1 | 1 | <2 mo. follow-up | 1 |
7,110 | 64.16699 | 0 | female | 0 | 4 | 813 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | under $11k | 0 | 2,727 | 0 | 0 | 10 | black | 28 | 41 | 0.756958 | 0.61499 | 1 | 1 | 0 | no | 0.7 | 0.6 | no dnr | 4 | 101 | 3.899902 | 68 | 24 | 36.79688 | 466.625 | 2.899902 | 4.299805 | 0.699951 | 138 | 7.389648 | 92 | 5 | null | 3 | 5 | no(M2 and SIP pres) | 5 |
7,111 | 65.34998 | 1 | male | 0 | 5 | 44 | Lung Cancer | Cancer | 3 | 12 | $11-$25k | 9 | 3,482 | 2,540.1289 | 3,109.50977 | 13 | white | 14.599609 | 9 | 0.723999 | 0.448975 | 1 | 1 | 0 | metastatic | 0.5 | 0.1 | no dnr | 5 | 123 | 0.699951 | 140 | 32 | 35.89844 | null | null | null | 4.199219 | 130 | null | 119 | 42 | null | null | 4 | <2 mo. follow-up | 4 |
7,112 | 54.40399 | 1 | female | 0 | 7 | 28 | Lung Cancer | Cancer | 2 | 12 | under $11k | 9 | 6,504 | 4,654.293 | 5,790.12891 | 6 | white | 11.099609 | 19 | 0.802979 | 0.580933 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr before sadm | -1 | 112 | 26.199219 | 140 | 12 | 38.5 | 222.5 | 1.399902 | 3.899902 | 0.699951 | 139 | 7.40918 | 194 | 7 | 2,250 | 0 | 0 | <2 mo. follow-up | 0 |
7,113 | 58.995 | 0 | male | 0 | 26 | 810 | CHF | COPD/CHF/Cirrhosis | 6 | 8 | under $11k | 9 | 45,541 | 30,684.9844 | 36,930.7188 | 28.25 | white | 37.796875 | 29 | 0.532959 | 0.333984 | 1 | 1 | 0 | no | 0.8 | 0.65 | no dnr | 26 | 118 | null | 53 | 28 | 38.29688 | 313.3125 | 1.599854 | 1.099854 | 2 | 145 | 7.459961 | 109 | 39 | 4,210 | 0 | 0 | SIP>=30 | 0 |
7,114 | 55.702 | 1 | male | 0 | 7 | 84 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 7 | $11-$25k | 0 | 10,151 | 6,042.293 | 6,985.70703 | 14.5 | white | 21.796875 | 20 | 0.860962 | 0.812988 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 89 | 10.5 | 79 | 20 | 36 | null | 3.699707 | 1 | 2 | 138 | null | 113 | 45 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,115 | 77.49799 | 1 | female | 1 | 6 | 6 | Coma | Coma | 0 | 10 | under $11k | 44 | 14,161 | 9,069.25 | 10,322.1797 | 52 | white | 22 | 54 | 0.42395 | 0.350952 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 1 | 113 | 17.097656 | 152 | 10 | 39.79688 | 190 | null | null | 0.899902 | 143 | 7.429688 | 176 | 22 | 3,695 | null | 0 | <2 mo. follow-up | 0 |
7,116 | 40.93399 | 0 | male | 0 | 8 | 804 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 6,717 | 4,903.5938 | 5,247.82812 | 8 | white | 15.898438 | 27 | 0.908936 | 0.846924 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 8 | 107 | 10.5 | 121 | 9 | 36.5 | 184 | 2.399902 | 1 | 1.299805 | 132 | 7.429688 | 233 | 16 | 4,575 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,117 | 74.146 | 0 | female | 0 | 4 | 803 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 3,434 | 1,934.5312 | 2,030.45996 | 12 | white | 16.5 | 19 | 0.871948 | 0.786987 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 4 | 116 | 6.5 | 116 | 24 | 36.39844 | 224.96875 | 3.199707 | 0.899902 | 0.5 | 130 | 7.459961 | 102 | 4 | 3,075 | 0 | 1 | no(M2 and SIP pres) | 1 |
7,118 | 34.64798 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 100 | 49,625 | 30,662.9688 | 34,789.4688 | null | white | 42.695313 | 98 | 0.043999 | 0.012999 | 14 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 3 | 103 | 21.796875 | 85 | 20 | 36.19531 | null | 3.099609 | 0.599976 | 13.398438 | 140 | null | 151 | 83 | 2,450 | null | 5 | <2 mo. follow-up | 5 |
7,119 | 74.19299 | 1 | male | 0 | 15 | 176 | Colon Cancer | Cancer | 1 | 20 | under $11k | 0 | 11,182 | 8,331.7891 | 11,199.0781 | 10.666664 | white | 15.5 | 19 | 0.819946 | 0.611938 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | dnr after sadm | 13 | 65 | 7.299805 | 64 | 20 | 36.09375 | null | 4.299805 | 0.599976 | 1 | 138 | 7.419922 | 261 | 22 | 2,475 | 1 | null | SIP>=30 | 1.166748 |
7,120 | 84.10394 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 41,670 | 25,552.9531 | 30,203.75 | 62 | white | 35.59375 | 74 | 0.451965 | 0.332947 | 1 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 8 | 96 | 4.899414 | 65 | 20 | 36.5 | null | 2.599609 | 4.299805 | 0.599976 | 140 | null | 80 | 7 | 860 | null | null | <2 mo. follow-up | 2.975098 |
7,121 | 69.71899 | 0 | male | 0 | 7 | 799 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 14,225 | 7,411.1992 | 9,426.57812 | 10.5 | white | 20.097656 | 57 | 0.845947 | 0.746948 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 104 | 12 | 130 | 26 | 35.5 | 257.125 | 3.099609 | 0.599976 | 1 | 141 | 7.339844 | 202 | 7 | 1,475 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,122 | 65.66998 | 1 | male | 1 | 13 | 13 | Coma | Coma | 0 | 11 | under $11k | 44 | 34,190 | 21,498.0781 | 24,579.3906 | 43 | white | 17.796875 | 34 | 0.623901 | 0.56189 | 2 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 11 | 153 | 11.298828 | 63 | 24 | 36.79688 | 153.03125 | 2.299805 | 0.799927 | 1.299805 | 142 | 7.329102 | 96 | 24 | 5,565 | null | 0 | <2 mo. follow-up | 0 |
7,123 | 85.48895 | 1 | female | 0 | 13 | 147 | CHF | COPD/CHF/Cirrhosis | 5 | 5 | under $11k | 9 | 13,746 | 9,013.9375 | 9,537.88281 | 9.5 | white | 17 | 36 | 0.81189 | 0.694946 | 1 | 1 | 1 | no | 0.8 | 0.6 | no dnr | 13 | 121 | 11.298828 | 147 | 34 | 40 | 202 | 3.299805 | 0.599976 | 0.899902 | 143 | 7.529297 | 398 | 14 | 2,183 | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,124 | 52.22198 | 0 | female | 0 | 9 | 799 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 9,511 | 6,064.7969 | 6,643.25781 | 11 | black | 11.398438 | 20 | 0.954956 | 0.921997 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 9 | 123 | 11.398438 | 124 | 36 | 38.79688 | 215 | 3.099609 | 1 | 1.399902 | 160 | 7.5 | 183 | 24 | 2,885 | 1 | 1 | no(M2 and SIP pres) | 1 |
7,125 | 61.59097 | 0 | female | 0 | 174 | 798 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 528,991 | 343,305.25 | 393,421.25 | 53.5 | white | 31.5 | 56 | 0.656982 | 0.557983 | 3 | 0 | 0 | no | 0.5 | 0.75 | no dnr | 174 | 116 | 15.699219 | 122 | 42 | 36.69531 | 126.65625 | 2.5 | 0.199982 | 0.699951 | 141 | 7.489258 | 78 | 8 | 9,000 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,126 | 87.44696 | 1 | female | 0 | 4 | 248 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 9 | 3,190 | 2,298.9609 | 2,387.2793 | 7 | white | 14.099609 | 31 | 0.841919 | 0.740967 | 1 | 1 | 1 | no | null | null | no dnr | 4 | 54 | 18.597656 | 117 | 35 | 39.5 | 328.5625 | 2 | 3.199707 | 3.5 | 130 | 7.359375 | 187 | 44 | 853 | null | null | adl>=4 (>=5 if sur) | 5.142578 |
7,127 | 74.64496 | 1 | male | 0 | 6 | 70 | Lung Cancer | Cancer | 3 | 9 | null | 0 | 5,841 | 3,918.9316 | 5,393.25781 | 15 | white | 17 | 32 | 0.684937 | 0.391968 | 1 | 0 | 0 | metastatic | 0.6 | 0.2 | dnr after sadm | 2 | 57 | 22.898438 | 63 | 8 | 35.69531 | 325.6875 | 2.899902 | 0.899902 | 12 | 137 | 7.399414 | 117 | 154 | 0 | 0 | 0 | null | 0 |
7,128 | 70.85797 | 0 | female | 0 | 9 | 795 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 15,318 | 9,469.1094 | 10,553.8125 | 29 | white | 28.796875 | 50 | 0.69397 | 0.528931 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 71 | 14.099609 | 119 | 8 | 38.5 | 115 | 1.699951 | 2.5 | 0.5 | 126 | 7.529297 | 122 | 15 | 1,478 | 6 | 3 | SIP>=30 | 3 |
7,129 | 38.54898 | 0 | female | 0 | 6 | 795 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 19,873 | 12,585.9062 | 12,943.2969 | 25 | white | 23.796875 | 27 | 0.860962 | 0.81189 | 4 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 6 | 69 | 9.398438 | 130 | 28 | 36.59375 | 134.6875 | 2.899902 | 1.5 | 0.699951 | 137 | 7.40918 | 74 | 14 | 2,368 | 1 | 0 | no(M2 and SIP pres) | 0 |
7,130 | 77.29498 | 1 | male | 1 | 33 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 37 | 99,954 | 64,701.1562 | 76,104.625 | 52.5 | white | 27.699219 | 48 | 0.535889 | 0.420959 | 1 | 1 | 0 | no | 0.05 | 0 | dnr after sadm | 30 | 68 | 15.298828 | 107 | 30 | 36.59375 | null | 2.699707 | 0.799927 | 0.799927 | 136 | null | 286 | 6 | 2,050 | null | 7 | <2 mo. follow-up | 7 |
7,131 | 44.34998 | 1 | male | 0 | 6 | 42 | Lung Cancer | Cancer | 2 | 12 | under $11k | 0 | 5,294 | 0 | 0 | 13 | black | 28.699219 | 21 | 0.482971 | 0.163971 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 2 | 118 | 6.899414 | 61 | 22 | 36.59375 | 460 | 1.5 | 0.399963 | 3.699707 | 133 | 7.40918 | 383 | 50 | 2,646 | 6 | 6 | <2 mo. follow-up | 6 |
7,132 | 64.91699 | 0 | male | 0 | 22 | 794 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 42,535 | 27,290.4375 | 30,593.1562 | 37 | white | 26.398438 | 47 | 0.74292 | 0.661987 | 3 | 0 | 0 | no | 0.5 | 0.45 | no dnr | 22 | 131 | 9.798828 | 77 | 43 | 36.29688 | 202.5 | 2.699707 | 1.599854 | 0.5 | 149 | 7.539062 | 119 | 12 | 3,795 | null | 0 | no(M2 and SIP pres) | 0 |
7,133 | 71.81396 | 0 | female | 0 | 10 | 790 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 17,482 | 11,167.8828 | 12,565.5391 | 38 | white | 23.296875 | 45 | 0.793945 | 0.725952 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 10 | 80 | 11.898438 | 101 | 32 | 37.5 | 252.375 | 2.899902 | 0.199982 | 1.199951 | 137 | 7.429688 | 87 | 18 | 2,675 | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,134 | 82.91296 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 37 | 17,620 | 9,559.0625 | 11,777.9141 | 18.5 | white | 26.5 | 41 | 0.363953 | 0.245972 | 5 | 1 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 82 | 5.5 | 85 | 24 | 36.39844 | null | 3.799805 | 0.399963 | 1 | 137 | null | 141 | 13 | 6,625 | null | 0 | <2 mo. follow-up | 0 |
7,135 | 76.646 | 0 | female | 0 | 4 | 790 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 3,833 | 2,677.7578 | 4,130.22656 | 5 | white | 17.097656 | 9 | 0.793945 | 0.563965 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 4 | 69 | 5 | 118 | 24 | 36.79688 | 161.65625 | 2.599609 | 3.099609 | 0.699951 | 135 | 7.379883 | 96 | 6 | 1,890 | 0 | 1 | no(M2 and SIP pres) | 1 |
7,136 | 60.70398 | 0 | female | 0 | 4 | 790 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 9 | $11-$25k | 0 | 7,557 | 5,053.4688 | 6,265.11719 | 11 | white | 13.599609 | 9 | 0.822998 | 0.710938 | 2 | 1 | 0 | yes | 0.8 | 0.6 | no dnr | 4 | 85 | 6.599609 | 88 | 24 | 37 | 270.3125 | null | null | 1.199951 | 137 | 7.399414 | 118 | 25 | 100 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,137 | 62.71899 | 1 | female | 1 | 3 | 3 | Coma | Coma | 0 | 8 | $25-$50k | 100 | 6,113 | 3,972.3184 | 4,416.71875 | 34 | white | 49.398438 | 90 | 0 | 0 | 1 | 0 | 0 | no | 0.1 | 0 | dnr after sadm | 2 | 45 | 17.597656 | 200 | 36 | 36.09375 | 114 | 1.899902 | 21.898438 | 2.599609 | 124 | 7.30957 | 34 | 12 | 144 | null | 1 | <2 mo. follow-up | 1 |
7,138 | 58.30798 | 0 | male | 0 | 10 | 789 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,487 | 6,871.7852 | 7,020.46875 | 10.5 | white | 23.398438 | 27 | 0.744995 | 0.598999 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 10 | 71 | 10.398438 | 76 | 24 | 35.79688 | 195 | 2.899902 | 2.299805 | 1.599854 | 134 | 7.429688 | 98 | 54 | 1,990 | 0 | 0 | SIP>=30 | 0 |
7,139 | 79.12396 | 1 | male | 0 | 16 | 42 | MOSF w/Malig | ARF/MOSF | 3 | 0 | under $11k | 9 | 17,993 | 13,135.5078 | 17,007 | 11.333328 | white | 30.097656 | 39 | 0.313965 | 0.200989 | 6 | 1 | 0 | metastatic | 0.5 | 0.1 | dnr before sadm | -1 | 84 | 6.199219 | 72 | 20 | 34.89844 | 228.5625 | 3.199707 | 2.199707 | 0.699951 | 132 | 7.389648 | 89 | 10 | 545 | 1 | 1 | <2 mo. follow-up | 1 |
7,140 | 74.724 | 1 | male | 0 | 15 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 9 | 26,976 | 17,403.8281 | 19,448.5625 | 31.333328 | white | 32.296875 | 72 | 0.56189 | 0.449951 | 1 | 0 | 0 | no | 0.35 | 0.3 | dnr after sadm | 1 | 102 | 43.195313 | 107 | 36 | 36.09375 | null | null | null | 3 | 138 | null | 94 | 33 | 1,950 | null | 5 | <2 mo. follow-up | 5 |
7,141 | 65.61499 | 1 | male | 0 | 7 | 25 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | >$50k | 0 | 11,004 | 5,491.8789 | 7,059.65625 | 11 | white | 22.296875 | 27 | 0.833984 | 0.728882 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 102 | 6.399414 | 75 | 38 | 35.5 | 288.875 | 2.099609 | 0.899902 | 1.699951 | 141 | 7.429688 | 78 | 18 | 1,830 | 0 | 0 | <2 mo. follow-up | 0 |
7,142 | 75.24396 | 1 | male | 1 | 46 | 46 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $25-$50k | 44 | 81,024 | 53,595.125 | 56,399.625 | 32.5 | white | 24.796875 | 39 | 0.592896 | 0.483948 | 1 | 1 | 1 | no | 0.75 | 0.1 | dnr after sadm | 3 | 75 | 9.699219 | 76 | 16 | 36 | null | 2.099609 | 1.399902 | 0.699951 | 129 | null | 135 | 16 | null | null | 6 | <2 mo. follow-up | 6 |
7,143 | 67.28296 | 0 | female | 0 | 8 | 785 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 10,817 | 7,378.5508 | 8,418.28906 | 12 | white | 13.898438 | 16 | 0.836914 | 0.733887 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 8 | 75 | 20.296875 | 68 | 10 | 38.09375 | 231.40625 | 4.299805 | 0.5 | 1 | 141 | 7.469727 | 107 | 16 | 704 | 0 | null | null | 0.494751 |
7,144 | 64.55298 | 0 | male | 0 | 4 | 782 | COPD | COPD/CHF/Cirrhosis | 4 | 6 | under $11k | 0 | 3,957 | 2,566.5977 | 2,682.63867 | 12 | white | 15.699219 | 7 | 0.903931 | 0.838989 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 4 | 111 | 8.298828 | 81 | 20 | 37.69531 | null | null | null | 1.099854 | 140 | null | 112 | 13 | null | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,145 | 76.271 | 1 | female | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 26 | 22,169 | 14,495.5469 | 16,692.6094 | 37.5 | white | 23.898438 | 53 | 0.659912 | 0.562988 | 2 | 1 | 0 | no | 0.25 | 0.1 | dnr after sadm | 8 | 107 | 6.799805 | 74 | 20 | 35.29688 | 137.03125 | 4.199219 | 1.299805 | 1.899902 | 136 | 7.339844 | 158 | 63 | 1,485 | null | null | <2 mo. follow-up | 3.133789 |
7,146 | 74.93195 | 1 | female | 0 | 8 | 21 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 9 | $11-$25k | 0 | 9,535 | 6,474.2812 | 8,051.58984 | 23 | white | 28.796875 | 37 | 0.384949 | 0.188995 | 1 | 1 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 1 | 115 | 12.798828 | 111 | 11 | 36.59375 | 160 | 2.799805 | 3 | 4.099609 | 137 | 7.549805 | 159 | 42 | 747 | 2 | 3 | <2 mo. follow-up | 3 |
7,147 | 82.85596 | 0 | female | 0 | 20 | 780 | CHF | COPD/CHF/Cirrhosis | 4 | 5 | under $11k | 0 | 16,190 | 12,133.25 | 11,202.6172 | 6.666664 | black | 14.398438 | 38 | 0.859985 | 0.767944 | 2 | 1 | 0 | no | 0.8 | 0.7 | dnr before sadm | -1 | 68 | 10.898438 | 104 | 24 | 36 | 157.5 | 3.899902 | 0.899902 | 2 | 139 | 7.209961 | 202 | 76 | 1,675 | null | 6 | adl>=4 (>=5 if sur) | 6 |
7,148 | 63.63898 | 1 | male | 0 | 8 | 758 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 10,863 | 6,378.3438 | 7,041.32812 | 18 | white | 25.796875 | 29 | 0.784912 | 0.714966 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 8 | 117 | 11.099609 | 100 | 21 | 37.59375 | 203.6875 | 3.299805 | 0.599976 | 3.599609 | 146 | 7.439453 | 103 | 63 | 2,540 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,149 | 71.474 | 0 | male | 0 | 9 | 777 | CHF | COPD/CHF/Cirrhosis | 5 | 5 | under $11k | 0 | 8,004 | 5,895.2852 | 5,674.44922 | 11 | black | 18.597656 | 31 | 0.856934 | 0.764893 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 9 | 53 | 10.199219 | 66 | 28 | 37 | null | 2.099609 | 5.199219 | 3.099609 | 136 | null | 98 | 45 | 190 | null | 4 | adl>=4 (>=5 if sur) | 4 |
7,150 | 73.45398 | 1 | female | 1 | 57 | 57 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 37 | 171,216 | 108,781.875 | 120,742.625 | 39.5 | white | 20.199219 | 23 | 0.648926 | 0.54895 | 14 | 0 | 0 | no | 0.6 | 0.4 | dnr after sadm | 57 | 107 | 14.099609 | 140 | 10 | 38 | 140 | null | null | 0.899902 | 132 | 7.429688 | 86 | 13 | 2,913 | null | 1 | <2 mo. follow-up | 1 |
7,151 | 57.08398 | 1 | female | 1 | 32 | 32 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 119,689 | 78,583.4375 | 101,367.812 | 53.25 | white | 23.699219 | 53 | 0.710938 | 0.622925 | 9 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 30 | 96 | 6.799805 | 130 | 20 | 36.5 | 400 | 2.099609 | 7.399414 | 0.599976 | 131 | 7.419922 | 148 | 6 | null | null | 1 | <2 mo. follow-up | 1 |
7,152 | 27.91499 | 0 | male | 0 | 32 | 775 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 51,737 | 34,929.4375 | 42,677.5625 | 29.75 | white | 26.597656 | 40 | 0.869995 | 0.823975 | 2 | 0 | 0 | no | 0.8 | 0.95 | no dnr | 32 | 75 | 6.299805 | 55 | 20 | 36.59375 | null | null | null | 0.899902 | 138 | null | 121 | 7 | 4,200 | null | 0 | no(M2 and SIP pres) | 0 |
7,153 | 43.31799 | 0 | female | 0 | 4 | 775 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | >$50k | 0 | 3,774 | 2,671.8027 | 2,576.83984 | 13 | white | 25.898438 | 30 | 0.861938 | 0.771973 | 1 | 1 | 0 | no | 0.5 | 0.25 | dnr before sadm | -1 | 106 | 9.398438 | 53 | 22 | 36.39844 | null | 4.099609 | 1.099854 | 1 | 138 | null | 92 | 14 | 900 | null | 6 | adl>=4 (>=5 if sur) | 6 |
7,154 | 73.27594 | 1 | female | 1 | 4 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 4,532 | 2,593.2266 | 2,610.09961 | 20 | white | 24.597656 | 69 | 0.770996 | 0.635986 | 1 | 1 | 0 | no | 0.8 | 0.7 | dnr after sadm | 3 | 110 | 17.699219 | 68 | 10 | 38.29688 | 218 | null | null | 1.099854 | 132 | 7.439453 | 158 | 25 | 1.569824 | null | 7 | <2 mo. follow-up | 7 |
7,155 | 59.504 | 1 | male | 1 | 6 | 6 | Coma | Coma | 3 | 12 | under $11k | 100 | 28,075 | 18,682.875 | 23,228.4844 | 61 | white | 39 | 80 | 0 | 0 | 9 | 0 | 0 | yes | 0.02 | 0.01 | dnr after sadm | 2 | 87 | 2.699707 | 69 | 22 | 36.39844 | null | 2.199707 | 1.299805 | 0.899902 | 133 | null | 91 | 5 | null | null | 0 | <2 mo. follow-up | 0 |
7,156 | 57.94699 | 1 | female | 0 | 8 | 171 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 9 | 12,181 | 7,889.6992 | 10,269.0781 | 30 | white | 24.796875 | 30 | 0.585938 | 0.47699 | 1 | 1 | 0 | metastatic | 0.5 | 0.2 | no dnr | 8 | 64 | 5.5 | 69 | 24 | 35.89844 | null | 3.699707 | 0.299988 | 1.699951 | 138 | null | 93 | 64 | 1,275 | 4 | 6 | SIP>=30 | 6 |
7,157 | 60.91699 | 1 | female | 0 | 8 | 466 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 6,069 | 4,591.3398 | 4,687.21875 | 9 | white | 23 | 30 | 0.840942 | 0.738892 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 8 | 97 | 10.199219 | 59 | 20 | 36.09375 | 195.21875 | 3.099609 | 0.699951 | 4.899414 | 140 | 7.329102 | 178 | 59 | 1,300 | 3 | 5 | no(M2 and SIP pres) | 5 |
7,158 | 77.93799 | 0 | female | 0 | 8 | 773 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 8,357 | 5,456.5352 | 5,842.47656 | 11.5 | black | 16.5 | 22 | 0.860962 | 0.770996 | 1 | 0 | 1 | no | 0.8 | 0.6 | no dnr | 8 | 113 | null | 76 | 20 | 36.5 | null | null | null | 1.099854 | 146 | null | 65 | 16 | null | 1 | 0 | no(M2 and SIP pres) | 0 |
7,159 | 53.85898 | 1 | female | 1 | 5 | 5 | Coma | Coma | 0 | 12 | null | 0 | 41,029 | 26,436.7656 | 29,938.9844 | 61 | black | 15.398438 | 25 | 0.838989 | 0.806885 | 8 | 0 | 0 | no | 0.8 | 0.9 | no dnr | 5 | 116 | 19.199219 | 62 | 18 | 35.59375 | 390.4375 | 4.399414 | 0.699951 | 0.799927 | 133 | 7.259766 | 330 | 18 | 3,400 | null | null | <2 mo. follow-up | 1.609131 |
7,160 | 74.46698 | 1 | female | 0 | 11 | 634 | CHF | COPD/CHF/Cirrhosis | 2 | 17 | >$50k | 0 | 16,886 | 9,589 | 10,968.9297 | 30 | white | 34.898438 | 68 | 0.53894 | 0.340942 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 11 | 67 | 9.5 | 116 | 12 | 35.59375 | 344 | null | null | 1.399902 | 112 | 7.459961 | 168 | 16 | 2,128 | null | 0 | null | 0 |
7,161 | 48.181 | 1 | male | 1 | 67 | 67 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 121,285 | 82,648 | 90,871.0625 | 16.25 | white | 28.597656 | 38 | 0.727905 | 0.643921 | 21 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 58 | 72 | 12.5 | 50 | 24 | 36.19531 | 282 | 4.199219 | 0.699951 | 1.599854 | 141 | 7.299805 | 123 | 25 | 2,260 | 2 | null | null | 1.838867 |
7,162 | 49.96298 | 0 | male | 0 | 12 | 770 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 26,074 | 16,713.625 | 19,144.8281 | 16.5 | white | 33.796875 | 43 | 0.656982 | 0.55896 | 4 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 12 | 124 | 16.296875 | 180 | 37 | 38 | 367.5 | 2.299805 | 0.799927 | 0.899902 | 135 | 7.459961 | 114 | 29 | 2,024 | 0 | 3 | no(M2 and SIP pres) | 3 |
7,163 | 62.48297 | 0 | male | 0 | 18 | 769 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 0 | 50,318 | 33,684.7812 | 35,248.0312 | 20.666656 | white | 32.796875 | 35 | 0.591919 | 0.483948 | 6 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 18 | 74 | 6.599609 | 72 | 16 | 38.09375 | null | 2.099609 | 4.899414 | 0.899902 | 138 | null | 91 | 4 | 1,750 | 1 | 0 | no(M2 and SIP pres) | 0 |
7,164 | 41.37399 | 0 | female | 0 | 87 | 769 | Coma | Coma | 0 | 14 | null | 61 | 161,771 | 111,000.875 | 123,108.25 | 27 | white | 17.898438 | 16 | 0.697998 | 0.644897 | 7 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 87 | 72 | 11.599609 | 58 | 22 | 36.5 | null | 3.799805 | 0.899902 | 0.699951 | 140 | null | 91 | 11 | 475 | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,165 | 68.73895 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 10 | under $11k | 0 | 51,447 | 32,388.7031 | 38,091.2188 | 51 | black | 56.296875 | 111 | 0.001 | 0 | 12 | 0 | 0 | yes | 0.05 | 0.05 | dnr after sadm | 3 | 45 | 26.699219 | 122 | 44 | 40.79688 | 305 | 2 | 1.699951 | 6 | 134 | 7.299805 | 73 | 76 | 0 | null | 0 | <2 mo. follow-up | 0 |
7,166 | 32.26599 | 0 | female | 0 | 11 | 766 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 29,835 | 19,437.3906 | 22,718.9688 | 25.5 | white | 25.898438 | 34 | 0.85498 | 0.804932 | 4 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 11 | 114 | 5.5 | 60 | 20 | 36.19531 | null | 3.699707 | 1 | 1.399902 | 145 | null | 282 | 31 | null | null | 0 | null | 0 |
7,167 | 77.27594 | 1 | female | 0 | 10 | 148 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | null | 26 | 13,611 | 8,746.2656 | 9,409.88281 | 15 | white | 29.796875 | 33 | 0.487976 | 0.28595 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 2 | 64 | 27.699219 | 77 | 34 | 36 | 55 | 1.899902 | 1.299805 | 2.599609 | 147 | 7.379883 | 90 | 62 | 1,123 | null | 1 | SIP>=30 | 1 |
7,168 | 67.87396 | 0 | female | 0 | 10 | 763 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 11,873 | 8,039.5586 | 10,097.7969 | 14.5 | black | 11.599609 | 17 | 0.795898 | 0.567993 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | dnr after sadm | 9 | 112 | 14.199219 | 74 | 32 | 36.39844 | 157.125 | 4.5 | 2.199707 | 2 | 140 | 7.459961 | 124 | 39 | 1,625 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,169 | 51.06598 | 1 | female | 0 | 13 | 58 | MOSF w/Malig | ARF/MOSF | 1 | 10 | under $11k | 0 | 10,079 | 7,440.2852 | 9,969.3125 | 20.5 | black | 23.796875 | 44 | 0.719971 | 0.633911 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 2 | 143 | 16.5 | 72 | 10 | 38.5 | 221.65625 | 3.299805 | 1.799805 | 1.699951 | 142 | 7.459961 | 155 | 46 | 3,680 | 6 | 3 | <2 mo. follow-up | 3 |
7,170 | 52.99399 | 1 | male | 1 | 13 | 13 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 31,891 | 20,829.9844 | 24,705.5156 | 47 | white | 32.09375 | 45 | 0.601929 | 0.411987 | 1 | 0 | 0 | no | null | null | dnr after sadm | 10 | 118 | 6.899414 | 76 | 20 | 35.59375 | 381.625 | 4.099609 | 1.199951 | 1.599854 | 131 | 7.429688 | 120 | 55 | 1,450 | null | null | <2 mo. follow-up | 2.875977 |
7,171 | 50.26999 | 1 | male | 0 | 4 | 397 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 3,801 | 2,191.418 | 2,141.97852 | 4 | black | 21.296875 | 28 | 0.906982 | 0.843994 | 1 | 0 | 0 | no | 0.76 | 0.6 | no dnr | 4 | 97 | 12.599609 | 65 | 24 | 36.5 | 309.5 | 4.599609 | 2.5 | 1 | 136 | 7.40918 | 103 | 18 | 2,000 | 2 | 3 | no(M2 and SIP pres) | 3 |
7,172 | 46.86398 | 1 | male | 0 | 3 | 513 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 3,070 | 2,063.2363 | 2,431.10938 | null | black | 9.599609 | 9 | 0.853882 | 0.675903 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 3 | 128 | 9.599609 | 110 | 60 | 39.29688 | 98.5625 | 1.399902 | 1.099854 | 0.599976 | 138 | 7.40918 | 121 | 4 | 4,730 | 0 | 2 | SIP>=30 | 2 |
7,173 | 74.75195 | 1 | female | 0 | 9 | 78 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 0 | 7,948 | 5,618.1289 | 7,480.72656 | 5 | white | 19.296875 | 8 | 0.572998 | 0.378967 | 1 | 1 | 0 | metastatic | 0.4 | 0.3 | dnr after sadm | 2 | 142 | 5.199219 | 70 | 24 | 35.89844 | 323.75 | 3.899902 | 0.899902 | 1.299805 | 144 | 7.459961 | 172 | 30 | 1,350 | 0 | null | null | 0.494751 |
7,174 | 60.33099 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | null | 9 | 103,796 | 66,242.3125 | 78,435.375 | 44.333313 | white | 28.296875 | 53 | 0.728882 | 0.644897 | 1 | 1 | 0 | no | 0.6 | 0.6 | dnr after sadm | 20 | 67 | 9.5 | 110 | 32 | 35.79688 | null | 3.899902 | 0.899902 | 0.899902 | 138 | null | 149 | 9 | 850 | null | 5 | <2 mo. follow-up | 5 |
7,175 | 90.31598 | 0 | female | 0 | 23 | 759 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 27,841 | 19,648.4531 | 20,654.6875 | 17.666656 | white | 19.597656 | 33 | 0.782959 | 0.711914 | 1 | 0 | 0 | no | 1 | 0.8 | no dnr | 23 | 58 | 11.398438 | 65 | 24 | 37.89844 | 152 | 2.199707 | 0.299988 | 0.599976 | 141 | 7.509766 | 121 | 20 | 2,005 | 7 | 6 | adl>=4 (>=5 if sur) | 6 |
7,176 | 64.56897 | 1 | male | 0 | 4 | 387 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,765 | 3,704.4961 | 4,495.51953 | 11 | white | 18.199219 | 32 | 0.684937 | 0.390991 | 1 | 0 | 0 | metastatic | 0.1 | 0 | no dnr | 4 | 143 | 23.5 | 128 | 32 | 36.19531 | 379.5625 | 2.699707 | 0.299988 | 0.799927 | 137 | 7.449219 | 104 | 14 | 3,655 | 1 | null | null | 1.166748 |
7,177 | 52.88199 | 0 | male | 0 | 4 | 759 | CHF | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 0 | 5,504 | 2,770.3203 | 3,449.53906 | 14 | white | 14.699219 | 31 | 0.928955 | 0.878906 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 119 | 21.5 | 115 | 8 | 38.19531 | 305.6875 | 2.099609 | 5.5 | 1.899902 | 149 | 7.459961 | 245 | 80 | 2,510 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,178 | 57.69498 | 1 | female | 1 | 12 | 12 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 11,371 | 7,853.918 | 10,265.3438 | 13 | white | 20.199219 | 17 | 0.658936 | 0.355957 | 1 | 0 | 0 | metastatic | 0.1 | 0 | dnr before sadm | 0 | 74 | 8.398438 | 110 | 28 | 36 | 376.1875 | 3 | 0.899902 | 0.699951 | 133 | 7.489258 | 107 | 7 | null | null | 0 | <2 mo. follow-up | 0 |
7,179 | 75.14899 | 1 | female | 0 | 38 | 140 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | under $11k | 37 | 81,821 | 56,451.2188 | 68,577.0625 | 42 | white | 32 | 73 | 0.327942 | 0.212982 | 9 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 38 | 58 | 11.398438 | 99 | 12 | 36.59375 | 126.25 | 2.799805 | 0.599976 | 1.5 | 139 | 7.389648 | 227 | 42 | 2,110 | null | 0 | SIP>=30 | 0 |
7,180 | 70.28296 | 0 | female | 0 | 4 | 757 | COPD | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 3,537 | 2,384.1836 | 2,320.75977 | 14 | white | 11 | 13 | 0.918945 | 0.862915 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 4 | 122 | 30.296875 | 300 | 12 | 36.29688 | 225 | 2 | 0.299988 | 0.599976 | 138 | 7.389648 | 171 | 28 | 2,465 | 2 | null | SIP>=30 | 1.838867 |
7,181 | 83.24194 | 0 | female | 0 | 20 | 757 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 42,356 | 24,962.9844 | 30,839.2188 | 15.666664 | white | 21.796875 | 28 | 0.758911 | 0.681885 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 20 | 59 | 6.799805 | 58 | 24 | 35.19531 | null | 2.599609 | 1.099854 | 2.399902 | 150 | null | 181 | 32 | 1,400 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,182 | 54.09998 | 0 | female | 0 | 9 | 756 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | $11-$25k | 0 | 20,297 | 12,216.4219 | 13,503.5391 | 29 | white | 26.199219 | 60 | 0.812988 | 0.75 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 9 | 115 | 4.399414 | 69 | 24 | 36.39844 | null | 3.299805 | 0.599976 | 0.799927 | 140 | null | 85 | 15 | null | 2 | 5 | SIP>=30 | 5 |
7,183 | 75.92297 | 1 | female | 0 | 20 | 68 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 0 | 43,953 | 28,345.7969 | 35,247.0938 | 35.333313 | white | 44.898438 | 69 | 0.125 | 0.056 | 1 | 0 | 0 | yes | 0 | 0 | no dnr | 20 | 113 | 6.599609 | 82 | 20 | 37 | null | 2.699707 | 0.799927 | 1 | 146 | null | 115 | 16 | 3,117 | null | 2 | null | 2 |
7,184 | 78.87994 | 0 | male | 0 | 57 | 754 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $25-$50k | 0 | 99,342 | 62,509.9688 | 71,938 | 32 | white | 16.097656 | 45 | 0.827881 | 0.769897 | 7 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 57 | 42 | 20.699219 | 66 | 3 | 34.39844 | 86 | 3 | 0.599976 | 2 | 136 | 7.259766 | 111 | 29 | 10 | null | 0 | no(M2 and SIP pres) | 0 |
7,185 | 47.41699 | 1 | female | 0 | 39 | 74 | MOSF w/Malig | ARF/MOSF | 1 | 12 | >$50k | 9 | 147,284 | 93,937.5625 | 110,033.688 | 47 | white | 19.796875 | 35 | 0.62793 | 0.524902 | 16 | 0 | 0 | metastatic | 0.25 | 0.1 | dnr before sadm | -1 | 68 | 12.199219 | 71 | 20 | 36.69531 | 352 | 2.599609 | 5.399414 | 1.099854 | 128 | 7.489258 | 107 | 18 | 2,750 | 0 | 0 | SIP>=30 | 0 |
7,186 | 25.659 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 41 | 50,963 | 31,926.7188 | 36,235.4688 | 54 | white | 24.898438 | 24 | 0.823975 | 0.764893 | 1 | 0 | 0 | no | 0.5 | 0.8 | dnr after sadm | 15 | 47 | 16.199219 | 66 | 24 | 36 | null | null | null | 1.599854 | 132 | null | 478 | 26 | 4,150 | null | 7 | <2 mo. follow-up | 7 |
7,187 | 68.27899 | 1 | male | 0 | 35 | 271 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | under $11k | 44 | 56,443 | 37,968.6875 | 41,037.75 | 27.5 | white | 17.699219 | 43 | 0.773926 | 0.700928 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 35 | 58 | 15.199219 | 80 | 13 | 36 | 174.28125 | 2.199707 | 1.599854 | 3.199707 | 131 | 7.449219 | 144 | 158 | 400 | null | 3 | no(M2 and SIP pres) | 3 |
7,188 | 58.04199 | 0 | male | 0 | 4 | 754 | CHF | COPD/CHF/Cirrhosis | 2 | 3 | under $11k | 0 | 4,621 | 2,825.0508 | 3,046.22852 | 5 | black | 12.099609 | 22 | 0.934937 | 0.889893 | 1 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 4 | 70 | 6.299805 | 101 | 24 | 35.39844 | 360 | 3.899902 | 1.099854 | 2.5 | 136 | 7.40918 | 101 | 30 | 1,848 | 0 | null | no(M2 and SIP pres) | 0.494751 |
7,189 | 64.534 | 1 | female | 0 | 10 | 195 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,137 | 6,217.2305 | 5,990.59766 | 9 | white | 16.796875 | 19 | 0.894897 | 0.824951 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 10 | 126 | 21.199219 | 124 | 34 | 39.89844 | 278 | 3 | 1.099854 | 1.199951 | 133 | 7.599609 | 329 | 16 | 3,980 | 0 | 0 | no(M2 and SIP pres) | 0 |
7,190 | 55.04999 | 0 | male | 0 | 29 | 752 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | $11-$25k | 0 | 60,692 | 40,551.0312 | 47,640 | 35.75 | white | 25.796875 | 37 | 0.784912 | 0.713989 | 4 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 29 | 102 | 12.398438 | 77 | 14 | 37.89844 | null | 3 | 0.599976 | 0.799927 | 142 | null | 96 | 31 | null | null | 1 | no(M2 and SIP pres) | 1 |
7,191 | 59.39999 | 0 | female | 0 | 83 | 751 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 166,403 | 0 | 0 | 40.5 | white | 26.597656 | 50 | 0.814941 | 0.700928 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 83 | 93 | 13.099609 | 108 | 16 | 36.5 | 316 | 4 | 0.599976 | 1 | 139 | 7.359375 | 108 | 12 | null | 0 | 0 | SIP>=30 | 0 |
7,192 | 83.92297 | 0 | female | 0 | 11 | 750 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | under $11k | 26 | 9,448 | 6,874.3594 | 6,855.29688 | 18 | black | 23.5 | 45 | 0.649902 | 0.549927 | 1 | 1 | 1 | no | 1 | 1 | no dnr | 11 | 115 | 15.398438 | 113 | 34 | 38.09375 | null | 1.899902 | 0.799927 | 1.899902 | 147 | 7.359375 | 213 | 81 | 3,130 | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,193 | 67.71497 | 1 | male | 0 | 5 | 26 | MOSF w/Malig | ARF/MOSF | 1 | 13 | $25-$50k | 0 | 10,883 | 6,483.543 | 7,480.54688 | 40 | white | 28 | 49 | 0.524902 | 0.408997 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 73 | 4.699219 | 96 | 24 | 35.79688 | 588 | 3 | 6.199219 | 3.699707 | 140 | 7.319336 | 143 | 70 | 2,825 | null | 2 | <2 mo. follow-up | 2 |
7,194 | 57.35199 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | null | under $11k | 0 | 44,357 | 30,127.9531 | 33,057.5938 | 34 | black | 20.699219 | 53 | 0.81897 | 0.758911 | 21 | 1 | 0 | no | 0 | 0 | dnr after sadm | 2 | 83 | 6.599609 | 76 | 24 | 36.5 | 233.3125 | 3.399902 | 0.799927 | 1.099854 | 137 | 7.459961 | 201 | 14 | 1.199951 | null | null | <2 mo. follow-up | 3.221191 |
7,195 | 80.44397 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | under $11k | 100 | 28,011 | 18,735.6094 | 20,484.6562 | 52 | black | 85.5 | 112 | 0 | 0 | 14 | 0 | 0 | no | null | null | dnr after sadm | 3 | 77 | 12.599609 | 129 | 30 | 36 | 296 | 2.799805 | 0.5 | 1 | 131 | 7.539062 | 96 | 10 | 2,800 | null | null | <2 mo. follow-up | 2.238281 |
7,196 | 65.59595 | 1 | male | 0 | 23 | 499 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 83,233 | 55,499.1562 | 62,521.3438 | 33.333313 | white | 26.597656 | 38 | 0.622925 | 0.518921 | 16 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 23 | 83 | 6.099609 | 93 | 20 | 37.59375 | 376.1875 | null | 1.299805 | 2.199707 | 137 | 7.519531 | 112 | 45 | 1,325 | null | 6 | null | 6 |
7,197 | 77.98798 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 38,200 | 19,655.75 | 25,473.1406 | 54.5 | white | 40.695313 | 50 | 0.342957 | 0.22699 | 1 | 0 | 0 | no | 0.2 | 0.15 | dnr after sadm | 12 | 63 | 12.5 | 69 | 12 | 38.19531 | 275.6875 | 2.899902 | 0.699951 | 0.699951 | 127 | 7.469727 | 172 | 15 | 2,166 | null | null | <2 mo. follow-up | 2.849609 |
7,198 | 70.66095 | 0 | male | 0 | 19 | 748 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 9 | 20,463 | 14,014.3594 | 15,503.6172 | 12.333328 | white | 22.097656 | 26 | 0.791992 | 0.723999 | 1 | 0 | 0 | no | 0.95 | 0.94 | no dnr | 19 | 109 | 26 | 80 | 10 | 36.5 | 303.3125 | 1.899902 | 9 | 1.199951 | 133 | 7.479492 | 67 | 29 | 1,219 | 1 | null | null | 1.166748 |
7,199 | 52.07098 | 1 | male | 0 | 7 | 89 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 9,472 | 6,581.4414 | 6,515.38672 | 8 | black | 16.199219 | 39 | 0.855957 | 0.762939 | 3 | 0 | 0 | no | 0.6 | 0.45 | no dnr | 7 | 69 | 25.296875 | 112 | 11 | 39.59375 | 116 | 2.299805 | 0.299988 | 0.899902 | 144 | 7.419922 | 121 | 16 | 1,206 | 7 | null | null | 5.199219 |
7,200 | 67.07697 | 0 | female | 0 | 22 | 746 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 50,276 | 32,878.0312 | 40,735.4062 | 45.333313 | white | 35.5 | 63 | 0.496948 | 0.295959 | 1 | 0 | 0 | yes | 0.85 | 0.8 | no dnr | 22 | 80 | 10.798828 | 72 | 20 | 36.19531 | null | 3.599609 | 1.199951 | 1.699951 | 122 | null | 283 | 51 | 1,460 | 2 | 1 | no(M2 and SIP pres) | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.